Genes to Cognition (G2C) is a neuroscience research programme with the dual aim of discovering fundamental biological principles and important insights into brain disease. G2C is an international collaborative program initiated by Dr. Seth Grant and supported by the Wellcome Trust following the discovery that multiprotein complexes formed by intracellular proteins and neurotransmitter receptors were important for neuronal plasticity and behaviour. Multiprotein complexes are involved with dozens of brain diseases, control multiple types of behaviours and are involved with the responses to drug treatments of mental disorders. Evolutionary studies show ancient forms of the complexes evolved over a billion years in single cell animals and may represent the origin of the brain. The long term goal is to understand the molecular basis of the extraordinarily complex brain of humans, how this complexity evolved, what it confers on behaviour and why brain evolution made us susceptible to mental illness. The G2C project has a unique database called G2Cdb that houses data resources from the research program and G2C has a very interesting educational program called G2COnline. ... [Information of the supplier, modified]
One of the main objectives of the HBP is to create and operate six Information and Communications Technology (ICT) Platforms, which are the core of the emerging HBP research infrastructure for brain research. Starting 30 March 2016, the scientific community worldwide can begin exploring the initial versions of the six HBP ICT Platforms. The Platforms embody the key objectives of the HBP, to gather and disseminate data describing the brain, to simulate and build models of the brain, to develop brain-inspired computing and robotics, and to create a global scientific community around the developing research infrastructure. The Platforms consist of prototype hardware, software tools, databases, programming interfaces, and initial data-sets, which will be refined and expanded on an on-going basis in close collaboration with end-users. The development of the Platforms has been the result of an extensive multidisciplinary effort involving more than 750 scientific collaborators and engineers from 114 institutions in 24 countries. The Platforms are as follows: the Neuroinformatics Platform, the Brain Simulation Platform, the High Performance Analytics and Computing Platform, the Medical Informatics Platform, the Neuromorphic Computing Platform and the Neurorobotics Platform. ... [Information of the supplier, modified]
